Sens Pharmaceutical (01530.HK) issued 1,537,000 shares due to the exercise of stock options.

The financial news app Zhitong reported that Sansei Pharmaceuticals (01530.HK) announced that from July 2, 2025 to July 29, a total of 1.537 million shares of stock were issued due to the exercise of stock purchase rights granted under the company's stock purchase plan approved on May 23, 2015.